ArticleFrontiers in nutrition2026
Global, regional and national burden of colorectal cancer attributable to low-fiber diet from 1990 to 2021: a systematic analysis of the global burden of disease study 2021.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Low-fiber diet is a modifiable dietary risk factor for colorectal cancer (CRC), but its long-term attributable burden and socioeconomic disparities remain insufficiently characterized. This study aimed to assess the global, regional, and national burden of colorectal cancer attributable to low-fiber diet (CRC-LFD) from 1990 to 2021 and to project future trends. Methods: Data were obtained from the Global Burden of Disease Study 2021. The estimation of CRC-LFD burden was based on the GBD comparative risk assessment framework, which integrates population-level exposure distributions, theoretical minimum risk exposure levels, and relative risks derived from meta-analyses to calculate population attributable fractions. Deaths, disability-adjusted life years (DALYs), age-standardized mortality rates (ASMRs), and age-standardized DALY rates (ASDRs) were analyzed. The Socio-demographic Index (SDI) was used to assess burden patterns across development levels. Das Gupta decomposition was applied to quantify the contributions of population growth, population aging, and epidemiological change. Cross-national inequality was evaluated using the Slope Index of Inequality and Concentration Index. Future trends to 2045 were projected using the Nordpred model. Results: From 1990 to 2021, global DALYs and deaths attributable to CRC-LFD increased by 24 and 36%, respectively, whereas ASDR and ASMR declined. The largest absolute DALY burden occurred in middle SDI regions, while the highest ASDR and ASMR were observed in high SDI regions. Among individuals younger than 80 years, males had higher attributable DALYs and deaths than females. Inequality analyses indicated persistent socioeconomic disparities, with relative inequality showing an increasing trend. Decomposition analysis suggested that, despite declining age-standardized rates, the absolute burden continued to rise mainly because of demographic changes, particularly population growth and aging. Projections indicated that deaths and DALYs would continue to increase by 2045, although ASDR and ASMR were expected to decline. Conclusion: CRC-LFD shows a paradoxical pattern of declining age-standardized rates but increasing absolute burden. These findings highlight the need to incorporate dietary fiber promotion into comprehensive CRC prevention strategies, develop systematic dietary policies, and implement SDI-specific interventions. As an ecological study, the results should be interpreted at the population level and cannot establish individual-level causality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.